Eating Disorders News and Research

Latest Eating Disorders News and Research

Shire announces FDA approval of Vyvanse Capsules for binge eating disorder

Shire plc announced today that the U.S. Food and Drug Administration approved Vyvanse (lisdexamfetamine dimesylate) Capsules (CII), the first and only medication for the treatment of moderate to severe binge eating disorder (B.E.D.) in adults, shown to significantly reduce the mean number of binge days per week.

30 Jan 2015

LCS Therapeutics collaborates to commercialize patent on method to treat binge eating disorder

LCS Therapeutics announced today that it has entered into a strategic collaboration with Lucerne Biosciences, LLC to commercialize U.S. Patent No. 8,318,813 entitled "Method of Treating Binge Eating Disorder."

26 Dec 2014

Researchers use MRI techniques to study consequences of anorexia nervosa on brain structure

Researchers from the Translational Developmental Neuroscience Lab led by Professor Stefan Ehrlich at the Department of Child and Adolescent Psychiatry and Psychotherapy of the University Hospital Carl Gustav Carus at the TU Dresden (Faculty of Medicine) used state-of-the-art magnetic resonance imaging (MRI) techniques to investigate the consequences of anorexia nervosa on brain structure.

3 Dec 2014

One third of male adolescents inaccurately perceive their weight, shows study

Almost one third of male adolescents inaccurately perceive their weight. This can influence their eating habits and, consequently, their health, according to a study led by the UAB and conducted with 600 teenage boys from Barcelona and surrounding areas.

20 Nov 2014

Alzheimer's drug may reduce addictive and impulsive behavior associated with binge eating

The Alzheimer's drug memantine may perform double-duty helping binge eaters control their compulsion.

14 Nov 2014

New drug naming system to be presented at ECNP conference in Berlin

What's in a name? Doctors have found that the name of the drug you are prescribed significantly influences how the patient sees the treatment.

20 Oct 2014

The Female Athlete Triad: A medical condition in active girls and women

Sophie is a 15 year old cross country runner who has a history of a foot stress fracture and shin splints. Often she does not eat prior to her workouts.

17 Oct 2014

Weight-normative approach could be harmful to patients, shows study

A new review of the way health care professionals emphasise weight to define health and wellbeing suggests the approach could be harmful to patients.

8 Oct 2014

Childhood eating disorders could have underlying psychological issues, researchers warn

Researchers at the University of Montreal and its affiliated CHU Sainte-Justine children's hospital are warning parents that difficult eaters could have underlying psychological issues, as they have found that restrictive behaviours can appear before puberty.

8 Oct 2014

Researchers demonstrate involvement of ClpB protein in eating disorders

Eating disorders (ED) such as anorexia nervosa, bulimia, and binge eating disorder affect approximately 5-10% of the general population, but the biological mechanisms involved are unknown. Researchers at Inserm Unit 1073, "Nutrition, inflammation and dysfunction of the gut-brain axis" (Inserm/University of Rouen) have demonstrated the involvement of a protein produced by some intestinal bacteria that may be the source of these disorders.

7 Oct 2014

Women who accept their imperfections may experience more positive body image

Women who accept and tolerate their imperfections appear to have a more positive body image despite their body mass index (BMI) and are better able to handle personal disappointments and setbacks in their daily lives.

30 Sep 2014

Anamorelin drug safe and well tolerated in advanced non-small cell lung cancer, Phase III trial reveals

A new drug, anamorelin, improves appetite and body mass in patients with advanced lung cancer who are suffering cancer anorexia and cachexia, according to phase III data presented at the ESMO 2014 Congress in Madrid, Spain.

29 Sep 2014

Helsinn to present Phase III trial data of anamorelin at ESMO Congress

Helsinn Group, a company focused on building quality cancer care, today announces that Phase III data from the largest trial program of its kind to date in anamorelin, a novel, once-daily ghrelin receptor agonist in development for cancer-anorexia-cachexia (CACS) in non-small cell lung cancer will be presented at the 38th European Society for Medical Oncology Congress in Madrid, Spain, in 2014.

25 Sep 2014

FDA approves Contrave extended-release tablets for chronic weight management

Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.

11 Sep 2014

Simple question about appetite may help reduce risk of dying

A simple question about appetite can provide insights into old people's general health that may help reduce their risk of dying.

11 Sep 2014

OCD diagnosis raises risk of subsequent schizophrenia

Patients who are diagnosed with obsessive–compulsive disorder are at increased risk of developing schizophrenia and schizophrenia spectrum disorders, a longitudinal study reports.

5 Sep 2014

Longer looks: Alzheimer's and a marriage; racism in medicine; abortion restrictions in Texas

The US, which has a mostly private health-care system, manages to spend more on its public health-care system than countries where the health-care system is almost entirely public. America's government spends more, as a percentage of the economy, on public health care than Canada, the United Kingdom, Japan or Australia. And then it spends even more than that on private health care.

5 Sep 2014

Researchers observe link between eating disorders and several autoimmune diseases

Finnish researchers have observed an association between eating disorders and several autoimmune diseases with different genetic backgrounds. These findings support the link between immune-mediated mechanisms and development of eating disorders.

26 Aug 2014

Positive emotions may play exacerbating role in fueling anorexia nervosa

Positive emotions - even those viewed through a distorted lens - may play an exacerbating role in fueling eating disorders like anorexia nervosa, which has a death rate 12 times higher for females between the ages of 15 and 24 than all other causes of death combined, according to a Rutgers study.

4 Aug 2014